Articles by James Calloway
Teva Q2 Preview: Emalex Charge May Mask Underlying Progress
Teva's Q2 results face a $700M Emalex charge that could neutralize branded-drug growth, with consensus EPS near zero. Revenue is forecast at $4.058B.
Microsoft's $40B AI Spend Under Microscope as Earnings Loom
Microsoft heads into earnings with a $40 billion capex target, raising questions about AI investment returns. Azure growth and cash conversion are key metrics.
3M Shares Jump 8.5% as Earnings Beat Drives Valuation Expansion
3M shares climbed 8.5% to $172.62 following a strong earnings report, with the valuation multiple expanding more than the guidance increase, signaling investor confidence in long-term growth.
Ford's Blue Gains Offset Pro Weakness Ahead of Q2 Earnings
Ford Motor (NYSE:F) is set to report Q2 earnings Tuesday, with Blue segment growth expected to offset a decline in Pro profits. Analysts estimate EPS of $0.33.
Alaska Air Faces Integration Challenges as Virgin America Brand Fades
Alaska Air's dual-brand strategy faces scrutiny as Virgin America is phased out. The combined equity value of its two major acquisitions is $3.6 billion, representing 68% of market cap.
Cathie Wood Invests $50 Million in Tesla Amid Earnings Slump
Cathie Wood's ARK Investment Management bought $50 million in Tesla shares after Q2 earnings missed estimates, betting on margin recovery amid a 17.8% weekly stock decline.
IonQ Faces Revenue Quality Test Ahead of Q2 Earnings Release
IonQ's Q2 report on August 5 will test if funded organic demand supports its $12.2B valuation. Stock fell 3.6% Friday, down 5.6% for the week.
GE Vernova Dips 4% as Cash Flow Timing Raises Investor Concerns
GE Vernova shares slipped 4% as investors focused on cash flow timing, despite a record $176 billion backlog and robust demand from data centers.
Super Micro Shares Surge 24% on Margin Reset, $847 Million Profit Boost
Super Micro Computer shares surged 24% last week after the company revised its gross margin outlook, projecting $847 million in additional gross profit. The stock slipped 3.5% on Friday.
Tesla's $25B Capex Plan Spurs 18% Weekly Drop Amid Cash Flow Worries
Tesla shares slid 17.8% last week as a $25 billion-plus investment plan and negative free cash flow overshadowed record deliveries.

